Houlihan Financial Resource Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$600K Hold
500
– – 0.21% 72
2026
Q1
$460K Hold
500
– – 0.18% 77
2025
Q4
$524K Buy
500
+139
+39% +$133K 0.2% 73
2025
Q3
$275K Sell
361
-134
-27% -$99.7K 0.24% 67
2025
Q2
$372K Hold
495
– – 0.15% 83
2025
Q1
$409K Hold
495
– – 0.18% 78
2024
Q4
$382K Sell
495
-9
-2% -$7.45K 0.16% 85
2024
Q3
$447K Buy
+504
New +$453K 0.18% 80
2024
Q2
– Sell
-493
Closed -$384K – 83
2024
Q1
$384K Hold
493
– – 0.17% 79
2023
Q4
$287K Hold
493
– – 0.14% 83
2023
Q3
$271K Buy
+493
New +$254K 0.15% 82
2020
Q3
$44K Buy
+304
New +$47K 0.03% 179

Other funds holding LLY

Houlihan Financial Resource Group's LLY Position: Q2 2026 in Review

Houlihan Financial Resource Group held its Eli Lilly (LLY) position steady in Q2 2026 at 500 shares worth $600K. The position accounts for 0.21% of the portfolio, ranked #72.

Houlihan Financial Resource Group first reported a position in LLY in Q3 2020 and has held it in 12 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Houlihan Financial Resource Group held 500 shares of Eli Lilly worth $600K as of Q2 2026.
  • Houlihan Financial Resource Group left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.21% of Houlihan Financial Resource Group's portfolio in Q2 2026, its #72 holding.
  • Houlihan Financial Resource Group first reported a position in Eli Lilly in Q3 2020 and has held it in 12 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Houlihan Financial Resource Group's 13F filing for Q2 2026, filed 10 Aug 2026.